Hiroshi Sugiyama

Japan Science and Technology Agency, Kyoto University

Papers

2

Total Citations

129

H-Index

2

About

Hiroshi Sugiyama is a pioneer at the intersection of nucleic acid nanotechnology and synthetic biology, with a core focus on engineering RNA–protein complexes for therapeutic and imaging applications. His major contributions lie in designing functional RNA nanostructures that respond to biological signals, effectively bridging the gap between synthetic molecular devices and living systems. In his seminal 2014 work (79 citations), Sugiyama demonstrated the construction and direct visualization of RNA–protein (RNP) complexes with programmable shapes, opening new avenues for molecular robotics and nanomedicine. He further advanced the field in 2017 (50 citations) by creating protein-driven RNA nanostructured devices that function in vitro and, remarkably, control mammalian cell fate—a breakthrough that showcases the potential of RNA nanotechnology for targeted therapeutics. By enabling nanostructures to detect and amplify protein signals within cells, Sugiyama’s work lays the foundation for smart, responsive biomaterials. His research not only pushes the boundaries of synthetic biology but also offers tangible pathways toward next-generation diagnostics and treatments, making him a leading figure in the design of biomolecular devices for medicine.

Research Focus

Key Achievements

2
H-Index
2
Papers
129
Total Citations
65
Avg Citations/Paper
🏆 Most Cited Paper
Engineering RNA–Protein Complexes with Different Shapes for Imaging and Therapeutic Applications
79 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Japan Science and Technology Agency, Kyoto University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago